The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis

One of the most important goals in the treatment of demyelinating diseases such as multiple sclerosis (MS) is, in addition to immunomodulation, reconstruction of the lost myelin sheath. The modulator of the central nervous system myelination is the metabotropic receptor coupled to the G-protein: GPR...

Descripción completa

Detalles Bibliográficos
Autores principales: Dziedzic, Angela, Miller, Elzbieta, Saluk-Bijak, Joanna, Bijak, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084627/
https://www.ncbi.nlm.nih.gov/pubmed/32182666
http://dx.doi.org/10.3390/ijms21051852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084627/
https://www.ncbi.nlm.nih.gov/pubmed/32182666
http://dx.doi.org/10.3390/ijms21051852

Ejemplares similares